Nakanishi Inc
TSE:7716
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Comtech Telecommunications Corp
NASDAQ:CMTL
|
US |
EV/EBITDA
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Enterprise Value to EBITDA (EV/EBITDA) ratio compares a company`s total enterprise value to its earnings before interest, taxes, depreciation, and amortization. It shows how much investors are paying for each dollar of the company`s earnings, including both equity and debt.
Valuation Scenarios
If EV/EBITDA returns to its 3-Year Average (9.5), the stock would be worth ¥2 919.99 (5% upside from current price).
| Scenario | EV/EBITDA Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 9.1 | ¥2 794 |
0%
|
| 3-Year Average | 9.5 | ¥2 919.99 |
+5%
|
| 5-Year Average | 10.2 | ¥3 139.81 |
+12%
|
| Industry Average | 8.3 | ¥2 551.95 |
-9%
|
| Country Average | 8.7 | ¥2 670.03 |
-4%
|
Forward EV/EBITDA
Today’s price vs future ebitda
| Today's Enterprise Value | EBITDA | Forward EV/EBITDA | ||
|---|---|---|---|---|
|
¥182.3B
|
/ |
Jan 2026
¥19.9B
|
= |
|
|
¥182.3B
|
/ |
Dec 2026
¥21.8B
|
= |
|
|
¥182.3B
|
/ |
Dec 2027
¥23.5B
|
= |
|
|
¥182.3B
|
/ |
Dec 2028
¥25.3B
|
= |
|
Forward EV/EBITDA shows whether today’s EV/EBITDA still looks high or low once future ebitda are taken into account.
Peer Comparison
| Market Cap | EV/EBITDA | P/E | ||||
|---|---|---|---|---|---|---|
| JP |
|
Nakanishi Inc
TSE:7716
|
232B JPY | 9.1 | -96.8 | |
| US |
|
Intuitive Surgical Inc
NASDAQ:ISRG
|
171.7B USD | 45.6 | 60.1 | |
| US |
|
Abbott Laboratories
NYSE:ABT
|
159.2B USD | 13.8 | 25.4 | |
| US |
|
Stryker Corp
NYSE:SYK
|
126B USD | 19.9 | 38.8 | |
| IE |
|
Medtronic PLC
NYSE:MDT
|
106.8B USD | 12.9 | 23.2 | |
| US |
|
Boston Scientific Corp
NYSE:BSX
|
96.2B USD | 19.7 | 33.2 | |
| DE |
|
Siemens Healthineers AG
XETRA:SHL
|
41.6B EUR | 10.9 | 19.4 | |
| US |
|
Edwards Lifesciences Corp
NYSE:EW
|
47.3B USD | 24 | 44.1 | |
| US |
|
IDEXX Laboratories Inc
NASDAQ:IDXX
|
46.1B USD | 30.8 | 43.5 | |
| US |
|
Becton Dickinson and Co
NYSE:BDX
|
44.3B USD | 10 | 25.2 | |
| US |
|
GE Healthcare Technologies Inc
NASDAQ:GEHC
|
32.5B USD | 11.3 | 15.6 |
Market Distribution
| Min | 0.1 |
| 30th Percentile | 6.7 |
| Median | 8.7 |
| 70th Percentile | 12.2 |
| Max | 214 699 781.2 |
Other Multiples
Nakanishi Inc
Glance View
Nakanishi Inc., a name that resonates with precision and innovation in the world of dental and industrial equipment, began its journey in 1930. Steeped in a tradition of excellence, the company has crafted a niche for itself by manufacturing high-speed rotary cutting instruments and dental equipment that are indispensable in modern-day medical and industrial applications. The company's operation is akin to a meticulous craftsman at work, where each product is an intersection of advanced technology and artistry. Nakanishi's core strength lies in its ability to produce highly reliable and precise tools that cater to both the delicate hands of dentists operating on patients and the intricate requirements of industrial manufacturing processes. The financial heartbeat of Nakanishi Inc. is its well-diversified revenue stream, driven by its dual focus on the dental and industrial sectors. The dental segment generates substantial income by providing state-of-the-art dental handpieces, which are a staple in medical facilities worldwide. Meanwhile, its industrial arm contributes robustly to the bottom line through products like electric motors and equipment for automation, enhancing efficiencies in various manufacturing fields. Nakanishi’s strategic geographic diversification, with manufacturing bases and sales networks spread across the globe, fortifies its market position and opens up additional revenue channels, ensuring resilience against market fluctuations and enabling sustainable, long-term growth.
